U.S. Beverage Stock News

LegalZoom.com (LZ) is back on investors’ radars after Barclays cut its rating to Underweight, flagging a relatively limited addressable market. This move coincides with recent earnings related and broader market pressures. See our latest analysis for LegalZoom.com. The share price has been under steady pressure, with a 1 day share price return of a 4.78% decline, a 30 day share price return of an 8.84% decline, and a 90 day share price return of a 40.32% decline. This leaves the latest close...

DLocal’s latest results, guidance and dividend DLocal (DLO) has drawn fresh attention after reporting quarterly and full year 2025 earnings, issuing operating profit guidance for 2026, and declaring a sizeable cash dividend to shareholders. See our latest analysis for DLocal. DLocal’s recent earnings release, 2026 profit guidance and cash dividend appear to have reset expectations, with a 10.14% 7 day share price return standing out against a weaker 90 day share price return and mixed 3 year...

Why One Stop Systems is attracting fresh attention One Stop Systems (OSS) is back in focus after reporting full year 2025 results that shifted from a prior net loss to net income, alongside guidance calling for 20% to 25% revenue growth in 2026. See our latest analysis for One Stop Systems. Despite the strong 2025 results and new 2026 guidance, the recent 15.4% 7-day share price decline and 7.0% 30-day share price return contrast with a 231.1% 1-year total shareholder return, suggesting...

On 20 March 2026, Central Bancompany, Inc. (NasdaqGS:CBC) was added to a wide range of Russell indices, including the Russell 1000, 2500, 3000, Midcap and their associated value, dynamic and benchmark variants. This broad Russell index inclusion significantly increases CBC’s presence in institutional portfolios, as index-tracking funds may now allocate to the bank, potentially enhancing liquidity and visibility among investors. We’ll now examine how Central Bancompany’s broad Russell index...

Willis Towers Watson (NasdaqGS:WTW) appointed a new global leader for its Work & Rewards business, signaling a refresh in a key advisory unit. The company launched an art insurance facility for collectors and galleries in Asia through a partnership focused on regional specialty coverage. Insurtech firm Thimble adopted WTW’s Radar Live platform to support modernized pricing for commercial lines. WTW shares trade at $293.36, with a value score of 2 and a mixed return profile that includes a...

Wondering if Waste Management at around US$224.94 is priced for perfection or still has room on the upside? This article walks through the key signals that matter for value focused investors. The stock has seen a 4.7% decline over the last 7 days and a 2.3% decline over the last 30 days, while returns sit at 3.0% year to date and 0.6% over the past year, with longer term returns of 52.1% over 3 years and 88.1% over 5 years. Recent price moves sit against a backdrop of ongoing interest in...

PDD Holdings recently confirmed it released its Q4 2025 results before the U.S. market opened on March 25, 2026, followed by an earnings call the same day. The earnings announcement comes as China reiterates its pledge to expand the global “trade pie,” a stance that could influence PDD’s export-focused business model amid ongoing trade tensions. We’ll now examine how expectations around PDD’s upcoming earnings, set against shifting trade policy signals, affect its existing investment...

If you are wondering whether Tenet Healthcare at around US$199.63 is still offering value or has already priced in its story, this breakdown is for you. The stock has recently seen a 5.7% decline over the last 7 days and a 13.2% decline over the last 30 days, while the 1 year return of 52.6% and very large 3 year and 5 year returns keep longer term holders focused. Recent headlines have focused on Tenet Healthcare as investors reassess hospital and healthcare operators, with attention on how...

How JPMorgan Chase (JPM) Has Been Trading Lately JPMorgan Chase (JPM) has seen mixed share performance recently, with a 0.9% gain over the past day and 1.9% over the past week, set against negative returns over the past month and over the past 3 months. See our latest analysis for JPMorgan Chase. The recent 1-day share price return of 0.86% and 7-day gain of 1.92% come after 30-day and 90-day share price returns of 5.92% and 11.17% declines. Longer term total shareholder returns of 18.82%...

The EU is preparing an antitrust decision on Alphabet under the Digital Markets Act, focusing on its conduct as a large online platform. The ruling is expected soon and could shape how Alphabet operates key services across European markets. Regulators are assessing whether Alphabet's current practices comply with new digital competition rules. Alphabet, traded as NasdaqGS:GOOGL, is heading into this regulatory decision with a mixed recent share price record. The stock is at $290.44 after a...

Earlier this week, Elliott Investment Management disclosed a multibillion-dollar stake in Synopsys and said it intends to engage management on boosting software and services revenue and overall profitability. The move introduces an activist shareholder into a company already redefining its role in chip and systems design through the Ansys combination, Arm collaboration, and NVIDIA-aligned AI and hardware-accelerated workflows. Next, we’ll examine how Elliott’s activist push for higher...

Wondering if TransMedics Group at around US$108.92 is priced for its future potential or already reflecting high expectations? This article breaks down what the current share price might be implying about the company. The stock has seen a 12.7% decline over the past week and an 18.9% decline over the last 30 days, even though the 1 year return sits at 53.9% and the 3 year return at 45.8%. Recent coverage has focused on TransMedics Group's position in the medical technology space and what its...

If you are wondering whether Merit Medical Systems at around US$67.55 is starting to look appealing or still feels expensive, the recent share performance gives you a useful starting point. The stock has seen a 3.8% decline over the last 7 days, a 17.8% fall over the last 30 days, and is down 21.9% year to date and 35.5% over the past year, while the 5 year return stands at 13.4%. These moves have put more attention on how the market currently prices Merit Medical Systems and whether...

Hamilton Lane stock reacts as Credit Income Fund clears key SEC milestone Hamilton Lane (HLNE) is back in focus after the U.S. Securities and Exchange Commission declared its Hamilton Lane Credit Income Fund effective, opening the door for broader access to middle market senior loan exposure. See our latest analysis for Hamilton Lane. Despite the SEC milestone for its Credit Income Fund, Hamilton Lane’s recent share price momentum has been weak, with a 30-day share price return of 6.98% and a...

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In this context of fluctuating performance, identifying small-cap stocks with potential insider buying can be an intriguing strategy for investors seeking opportunities that may not be immediately apparent in larger market trends.

ICON (NasdaqGS:ICLR) has drawn fresh attention after announcing a definitive partnership with Advarra to build a connected, research ready clinical trial site network that aims to simplify operations and widen trial access. See our latest analysis for ICON. Despite the Advarra agreement and recent conference appearances, ICON’s recent share price return has been mixed, with modest gains over the past month but a much weaker 90 day share price return of 44.9% and a 1 year total shareholder...

If you are wondering whether Capital One Financial at around US$184 per share still offers value, or if most of the opportunity is already reflected in the price, this article walks you through what the current valuation indicates about the stock. The share price has moved 0.7% over the past week, declined 11.4% over the last month and is down 25.5% year to date, while showing a 2.6% return over 1 year and 113.2% over 3 years. The recent pullback therefore sits against a much stronger...

Why Woodward is on investors’ radar today Woodward (WWD) is drawing attention after recent share price swings, with the stock up around 2% over the past day but down over the past month, prompting fresh interest in its valuation. See our latest analysis for Woodward. Beyond the latest 2.03% 1 day share price return, Woodward’s 90 day share price return of 17.56% and 1 year total shareholder return of 91.95% suggest momentum has been strong over both shorter and longer periods. If Woodward’s...

Over the last 7 days, the United States market has dropped 2.3%, but it has experienced a 13% rise over the past year, with earnings forecast to grow by 16% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability in an evolving market landscape.

Zillow Group (NasdaqGS:ZG) has entered a new multiyear partnership with Major League Baseball. The company will be the official real estate and home rentals marketplace partner across national broadcasts and in stadium integrations throughout the MLB season. Zillow Group, trading at a recent share price of $45.09, is tying its brand to one of the most widely watched sports leagues in the US. For investors following NasdaqGS:ZG, this move comes after a 31.3% decline year to date and a 37.4%...

Doppel Games has announced a collaboration with Kash to introduce real-time prediction markets for AI-driven battles in its Agent vs Agent (AvA) competitions, hosted on X (formerly Twitter). This partnership enables live, tradeable outcomes for these AI battles, creating a novel type of social-native entertainment. The matches, which feature AI doppelgangers of well-known personalities, are streamed live, allowing viewers to engage by predicting outcomes directly within their social media...

Event context for XPO XPO (XPO) recently drew investor interest after a period in which the stock showed a one-month return of about an 11% decline, even as its past three-month return stood near 32%. See our latest analysis for XPO. Recent trading has been choppy, with a 1 day share price return of 0.39% and a 30 day share price decline of 11.22%. However, the 90 day share price return of 32.02% and 1 year total shareholder return of 67.83% suggest that momentum has been stronger over the...

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it remains up by 13% over the past year with earnings projected to grow by 16% annually. In this context, identifying stocks that are trading below their intrinsic value can present opportunities for investors seeking to capitalize on potential long-term gains amidst fluctuating market conditions.

In March 2026, MBX Biosciences, Inc. reported wider net losses for the fourth quarter and full year 2025, while also filing multiple shelf registrations covering common stock, preferred stock, debt securities, warrants, and units. An interesting aspect of these filings is the US$78.01 million common stock shelf tied to an employee stock ownership plan, which highlights MBX Biosciences’ focus on equity-based incentives alongside broader capital-raising flexibility. Next, we will examine how...